pharma · Breast Cancer · Breastcancer · BCTX
BriaCell Therapeutics
BriaCell Therapeutics is a pharma organization headquartered in Philadelphia, USA. It trades on NYSE under ticker BCTX. Primary therapeutic focus areas include Breast Cancer, Breastcancer. NovaPharmaNews links 3 clinical
Philadelphia, USA HQ
2004 Founded
24 Employees
Public company Type
BCTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Philadelphia, USA
- Founded
- 2004
- Employees
- 24
- Programs
- 3
- Drugs
- 0
- Patents
- 1
SV-BR-1-GM
Phase 3 · mab · Breast Cancer
SV-BR-1-GM for Breast Cancer is a Phase 3 program (mab) at BriaCell Therapeutics with 2 ClinicalTrials.gov record(s).
Internal code BRI-ROL-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BriaCell Therapeutics
- Phase
- Phase 3
- Modality
- mab
- Indication
- Breast Cancer
- Status
- active
- Trials
- 2